Oxford Nanopore Technologies Ltd (ONT) - Total Liabilities
Based on the latest financial reports, Oxford Nanopore Technologies Ltd (ONT) has total liabilities worth GBX159.20 Million GBX (≈ $19.37K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ONT cash generation efficiency to assess how effectively this company generates cash.
Oxford Nanopore Technologies Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how Oxford Nanopore Technologies Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Oxford Nanopore Technologies Ltd (ONT) asset resilience to evaluate the company's liquid asset resilience ratio.
Oxford Nanopore Technologies Ltd Competitors by Total Liabilities
The table below lists competitors of Oxford Nanopore Technologies Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SSH Group Ltd
AU:SSH
|
Australia | AU$31.15 Million |
|
Soditech SA
PA:SEC
|
France | €4.43 Million |
|
LZ Technology Holdings Limited Class B Ordinary Shares
NASDAQ:LZMH
|
USA | $441.82 Million |
|
CSH Alliance Bhd
KLSE:7165
|
Malaysia | RM17.70 Million |
|
Temple Bar Investment Trust
LSE:TMPL
|
UK | GBX77.92 Million |
|
Nusa Palapa Gemilang PT Tbk
JK:NPGF
|
Indonesia | Rp80.84 Billion |
|
Scienture Holdings, Inc.
NASDAQ:SCNX
|
USA | $14.06 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Oxford Nanopore Technologies Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ONT stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Oxford Nanopore Technologies Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Oxford Nanopore Technologies Ltd (2012–2025)
The table below shows the annual total liabilities of Oxford Nanopore Technologies Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | GBX159.20 Million ≈ $19.37K |
+2.24% |
| 2024-12-31 | GBX155.71 Million ≈ $18.95K |
+16.89% |
| 2023-12-31 | GBX133.21 Million ≈ $16.21K |
+2.21% |
| 2022-12-31 | GBX130.33 Million ≈ $15.86K |
-5.48% |
| 2021-12-31 | GBX137.89 Million ≈ $16.78K |
+44.73% |
| 2020-12-31 | GBX95.28 Million ≈ $11.59K |
+72.58% |
| 2019-12-31 | GBX55.21 Million ≈ $6.72K |
+70.95% |
| 2018-12-31 | GBX32.30 Million ≈ $3.93K |
+25.55% |
| 2017-12-31 | GBX25.72 Million ≈ $3.13K |
+87.69% |
| 2016-12-31 | GBX13.71 Million ≈ $1.67K |
+65.34% |
| 2015-12-31 | GBX8.29 Million ≈ $1.01K |
+93.62% |
| 2014-12-31 | GBX4.28 Million ≈ $520.87 |
+38.19% |
| 2013-12-31 | GBX3.10 Million ≈ $376.94 |
+54.29% |
| 2012-12-31 | GBX2.01 Million ≈ $244.30 |
-- |
About Oxford Nanopore Technologies Ltd
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hard… Read more